EBR Systems, Inc., developer of the world’s only left ventricular endocardial pacing (LVEP) system for heart failure, today announced real-world findings from 100 patients across 31 US centers showing ...

A critical review finds that immunohistochemical injury timelines established in ventricular muscle cannot yet be reliably ...

Vincora (NeoChord, Inc. d/b/a Vincora), a medical technology company developing transcatheter therapies for mitral valve repair, today announced that the U.S. Food and Drug Administration (FDA) has ...

Researchers have built a subject-specific computational model of the complete human cardiac conduction system that reproduces ...

In the REAL PULSE prospective study, clinicians evaluated 1,160 AFib patients across 38 centres using the PulseSelect PFA ...

RV, a deep learning model that estimates right ventricular size and function from echocardiograms, and assesses how those ...

It’s a brain hemorrhage, yet the paralysis is surprisingly mild.”Have you ever felt that way?When caring for stroke patients, you may sometimes feel confused because the CT images do not seem to align ...

Medtronic (NYSE:MDT) reported positive real world registry results for its Sphere-9 catheter and PulseSelect PFA System at ...

The trial is designed to assess intrathecal doses of brezosiran in adults aged 25 to 70 years with genetically confirmed HD.

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced positive real-world registry results for the ...

RECOVER-HF pilot trial in JACC: Heart Failure. The study is the first randomized, double-blinded, sham-controlled evaluation of the company’s investigational VisONE™ Synchronized Diaphragmatic ...

For the study, the researchers looked at US Fire Administration records from 3,401 on-duty firefighter fatalities (mean age ...